Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1357 | Pituitary Basic | ICEECE2012

Lymphocyte subpopulations in Sheehan’s syndrome

Atmaca H. , Arasli M. , Yazici Z. , Armutcu F. , Tekin I.

There are a limited number of studies investigating the immunological alterations accompanying the Sheehan Syndrome. The aim of this study was to evaluate lymphocyte subsets in these patients.Flow cytofluorometry was used for the immunophenotyping of peripheral blood leukocytes from 15 patients (mean age 61.6±11.3, range 34–75 years) and 25 healthy controls (mean age 56.7±10.6, range 34–80 years). The percentages of CD3+, C...

ea0029p1541 | Pituitary Clinical | ICEECE2012

Results of pegvisomant therapy in patients with acromegaly

Kan E. , Atmaca A. , Ecemis G. , Atmaca H. , Colak R.

Introduction: Acromegaly is chronic debilitating disease related with excess GH and insülin-like growth factor 1 (IGF1) secretion. Pegvisomant is a GH receptor antagonist that competes with endogenous GH for its receptor and is often used as a medical therapy in patients with inadequate response to somatostatin analogs.Methods: Forty-six patients are followed with the diagnosis of acromegaly in our clinic. We present the results of six acromegalic p...